Hyperfine (NASDAQ:HYPR) Upgraded at Zacks Research

Zacks Research upgraded shares of Hyperfine (NASDAQ:HYPR) to a hold rating in a research note released on Thursday,Zacks.com reports.

A number of other equities analysts have also weighed in on HYPR. Lake Street Capital boosted their price objective on shares of Hyperfine from $2.00 to $2.50 and gave the company a “buy” rating in a research report on Thursday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a research note on Thursday, January 22nd. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Hyperfine currently has an average rating of “Hold” and an average price target of $1.45.

Hyperfine Trading Up 2.5%

HYPR stock opened at $1.24 on Thursday. The stock has a market cap of $120.49 million, a P/E ratio of -2.82 and a beta of 1.09. The company’s 50 day moving average is $1.15 and its two-hundred day moving average is $1.20. Hyperfine has a twelve month low of $0.53 and a twelve month high of $2.22.

Hyperfine (NASDAQ:HYPR) last released its earnings results on Wednesday, March 18th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.02. Hyperfine had a negative net margin of 262.29% and a negative return on equity of 95.09%. The company had revenue of $5.29 million for the quarter, compared to analyst estimates of $5.30 million. On average, equities research analysts predict that Hyperfine will post -0.57 earnings per share for the current year.

Institutional Trading of Hyperfine

A number of institutional investors have recently modified their holdings of the company. EP Wealth Advisors LLC acquired a new stake in Hyperfine during the 4th quarter worth approximately $34,000. Sanctuary Advisors LLC lifted its position in Hyperfine by 130.9% during the fourth quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company’s stock valued at $39,000 after buying an additional 22,638 shares in the last quarter. Tortoise Investment Management LLC acquired a new position in Hyperfine during the third quarter valued at approximately $65,000. Kathmere Capital Management LLC purchased a new stake in Hyperfine during the fourth quarter worth approximately $51,000. Finally, Millennium Management LLC purchased a new stake in Hyperfine during the fourth quarter worth approximately $55,000. Hedge funds and other institutional investors own 15.03% of the company’s stock.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.